Candel Therapeutics Inc (CADL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 13,207 | 11,177 | 8,130 | 8,141 | 8,757 |
| Operating Income | -13,207 | -11,177 | -8,130 | -8,141 | -8,757 |
| Interest Expense | 161 | 236 | 306 | 390 | 487 |
| Other Income | 2,099 | 6,617 | 15,815 | -5,542 | -1,402 |
| Pre-tax Income | -11,269 | -4,796 | 7,379 | -14,073 | -10,646 |
| Net Income Continuous | -11,269 | -4,796 | 7,379 | -14,073 | -10,646 |
| Net Income | $-11,269 | $-4,796 | $7,379 | $-14,073 | $-10,646 |
| EPS Basic Total Ops | -0.21 | -0.09 | 0.15 | -0.39 | -0.33 |
| EPS Basic Continuous Ops | -0.21 | -0.09 | 0.15 | -0.38 | -0.33 |
| EPS Diluted Total Ops | -0.21 | -0.09 | 0.13 | -0.39 | -0.33 |
| EPS Diluted Continuous Ops | -0.21 | -0.09 | 0.13 | -0.38 | -0.33 |
| EPS Diluted Before Non-Recurring Items | -0.21 | -0.09 | 0.13 | -0.40 | -0.33 |
| EBITDA(a) | $-13,012 | $-10,935 | $-7,885 | $-7,896 | $-8,512 |